{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T19:45:10Z","timestamp":1793907910587,"version":"4.8.0"},"reference-count":14,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,8]],"date-time":"2024-03-08T00:00:00Z","timestamp":1709856000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Regulatory Toxicology and Pharmacology"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.yrtph.2024.105590","type":"journal-article","created":{"date-parts":[[2024,3,8]],"date-time":"2024-03-08T04:16:44Z","timestamp":1709871404000},"page":"105590","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Taring the scales: Weight-of-evidence framework for biocompatibility evaluations"],"prefix":"10.1016","volume":"149","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0001-8537","authenticated-orcid":false,"given":"Stephanie M.","family":"Street","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Whitney V.","family":"Christian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.yrtph.2024.105590_bib1","doi-asserted-by":"crossref","first-page":"453","DOI":"10.14573\/altex.1709221","article-title":"Material-mediated Pyrogens in Medical Devices: Applicability of the In Vitro Monocyte Activation Test","volume":"35","author":"Borton","year":"2018","journal-title":"ALTEX"},{"key":"10.1016\/j.yrtph.2024.105590_bib4","series-title":"Biological Evaluation of Medical Devices \u2013 Part 1: Evaluation and Testing Within a Risk Management Process","year":"2018"},{"key":"10.1016\/j.yrtph.2024.105590_bib5","series-title":"Biological Evaluation of Medical Devices \u2013 Part 5: Test for In Vitro Cytotoxicity","year":"2009"},{"key":"10.1016\/j.yrtph.2024.105590_bib6","series-title":"Biological Evaluation of Medical Devices \u2013 Part 11: Tests for Systemic Toxicity","year":"2017"},{"key":"10.1016\/j.yrtph.2024.105590_bib7","series-title":"Biological Evaluation of Medical Devices \u2013 Part 12: Sample Preparation and Reference Materials","year":"2021"},{"key":"10.1016\/j.yrtph.2024.105590_bib8","series-title":"Biological Evaluation of Medical Devices \u2013 Part 17: Toxicological Risk Assessment of Medical Device Constituents","year":"2023"},{"key":"10.1016\/j.yrtph.2024.105590_bib9","series-title":"Biological Evaluation of Medical Devices \u2013 Part 18: Chemical Characterization of Materials","year":"2020"},{"key":"10.1016\/j.yrtph.2024.105590_bib10","series-title":"Biological Evaluation of Medical Devices \u2013 Part 19: Physico-Chemical, Morphological and Topographical Characterization of Materials","year":"2020"},{"key":"10.1016\/j.yrtph.2024.105590_bib11","unstructured":"Regulation (EU) 2017\/745 of the European Parliament and of the Council of 5 April 2017 on Medical Devices, Amending Directive 2001\/83\/EC, Regulation (EC) No 178\/2002 and Regulation (EC) No 1223\/2009 and Repealing Council Directives 90\/385\/EEC and 93\/42\/EEC."},{"issue":"6","key":"10.1016\/j.yrtph.2024.105590_bib12","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1002\/ieam.1953","article-title":"A Weight of Evidence Framework for Environmental Assessments: Inferring Quantities","volume":"13","author":"Suter","year":"2017","journal-title":"Integrated Environ. Assess. Manag."},{"issue":"5","key":"10.1016\/j.yrtph.2024.105590_bib13","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1002\/ieam.4271","article-title":"Systematic Review and Weight of Evidence Are Integral to Ecological and Human Health Assessments: They Need an Integrated Framework","volume":"16","author":"Suter","year":"2020","journal-title":"Integrated Environ. Assess. Manag."},{"key":"10.1016\/j.yrtph.2024.105590_fur1","series-title":"Guidance for Industry and Food and Drug Administration Staff Use of International Standard ISO 10993-1, \u201cBiological Evaluation of Medical Devices \u2013 Part 1: Evaluation and Testing Within a Risk Management Process","year":"2023"},{"key":"10.1016\/j.yrtph.2024.105590_fur3","series-title":"General Chapter, \u27e8161\u27e9 Medical Devices\u2014Bacterial Endotoxin and Pyrogen Tests","year":"2023"},{"key":"10.1016\/j.yrtph.2024.105590_fur2","series-title":"Biocompatibility Evaluation of Breathing Gas Pathways in Healthcare Applications \u2013 Part 1: Evaluation and Testing within a Risk Management Process","year":"2017"}],"container-title":["Regulatory Toxicology and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027323002400031X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027323002400031X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,7]],"date-time":"2024-06-07T09:18:12Z","timestamp":1717751892000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S027323002400031X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":14,"alternative-id":["S027323002400031X"],"URL":"https:\/\/doi.org\/10.1016\/j.yrtph.2024.105590","relation":{},"ISSN":["0273-2300"],"issn-type":[{"value":"0273-2300","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Taring the scales: Weight-of-evidence framework for biocompatibility evaluations","name":"articletitle","label":"Article Title"},{"value":"Regulatory Toxicology and Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yrtph.2024.105590","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"105590"}}